These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 29680336)

  • 1. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles.
    Knight DS; Zumbo G; Barcella W; Steeden JA; Muthurangu V; Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Kotecha T; Francis R; Rezk T; Quarta CC; Whelan CJ; Lachmann HJ; Wechalekar AD; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2019 May; 12(5):823-833. PubMed ID: 29680336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis.
    Boldrini M; Cappelli F; Chacko L; Restrepo-Cordoba MA; Lopez-Sainz A; Giannoni A; Aimo A; Baggiano A; Martinez-Naharro A; Whelan C; Quarta C; Passino C; Castiglione V; Chubuchnyi V; Spini V; Taddei C; Vergaro G; Petrie A; Ruiz-Guerrero L; Moñivas V; Mingo-Santos S; Mirelis JG; Dominguez F; Gonzalez-Lopez E; Perlini S; Pontone G; Gillmore J; Hawkins PN; Garcia-Pavia P; Emdin M; Fontana M
    JACC Cardiovasc Imaging; 2020 Apr; 13(4):909-920. PubMed ID: 31864973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial Amyloidosis: The Exemplar Interstitial Disease.
    Fontana M; Ćorović A; Scully P; Moon JC
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2345-2356. PubMed ID: 31422120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion Tensor Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.
    Khalique Z; Ferreira PF; Scott AD; Nielles-Vallespin S; Martinez-Naharro A; Fontana M; Hawkins P; Firmin DN; Pennell DJ
    Circ Cardiovasc Imaging; 2020 May; 13(5):e009901. PubMed ID: 32408830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?
    Cuddy SAM; Bravo PE; Falk RH; El-Sady S; Kijewski MF; Park MA; Ruberg FL; Sanchorawala V; Landau H; Yee AJ; Bianchi G; Di Carli MF; Cheng SC; Jerosch-Herold M; Kwong RY; Liao R; Dorbala S
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1325-1336. PubMed ID: 32417333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining echocardiographic predictors of outcome in cardiac amyloidosis by subtype.
    Singulane C; Sun D; Hu Z; Lee L; Sarswat N; Emami Neyestanak M; Patel AR; Lang RM; Addetia K
    Curr Probl Cardiol; 2024 Sep; 49(9):102729. PubMed ID: 38945183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional differences in prognostic value of cardiac valve plane displacement in systemic light-chain amyloidosis.
    Ochs MM; Fritz T; Arenja N; Riffel J; Andre F; Mereles D; Siepen FAD; Hegenbart U; Schönland S; Katus HA; Friedrich MGW; Buss SJ
    J Cardiovasc Magn Reson; 2017 Nov; 19(1):87. PubMed ID: 29121956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Native T1 Mapping, Extracellular Volume Mapping, and Late Gadolinium Enhancement in Cardiac Amyloidosis: A Meta-Analysis.
    Pan JA; Kerwin MJ; Salerno M
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1299-1310. PubMed ID: 32498919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis.
    Lin L; Li X; Feng J; Shen KN; Tian Z; Sun J; Mao YY; Cao J; Jin ZY; Li J; Selvanayagam JB; Wang YN
    J Cardiovasc Magn Reson; 2018 Jan; 20(1):2. PubMed ID: 29298704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis.
    Baggiano A; Boldrini M; Martinez-Naharro A; Kotecha T; Petrie A; Rezk T; Gritti M; Quarta C; Knight DS; Wechalekar AD; Lachmann HJ; Perlini S; Pontone G; Moon JC; Kellman P; Gillmore JD; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):69-80. PubMed ID: 31202744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study.
    Mohty D; Boulogne C; Magne J; Varroud-Vial N; Martin S; Ettaif H; Fadel BM; Bridoux F; Aboyans V; Damy T; Jaccard A
    Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):961-9. PubMed ID: 27194782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of survival stratification in patients with wild-type cardiac amyloidosis.
    Siepen FAD; Bauer R; Voss A; Hein S; Aurich M; Riffel J; Mereles D; Röcken C; Buss SJ; Katus HA; Kristen AV
    Clin Res Cardiol; 2018 Feb; 107(2):158-169. PubMed ID: 28956153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of novel imaging parameters derived from standard cardiovascular magnetic resonance in high risk patients with systemic light chain amyloidosis.
    Arenja N; Andre F; Riffel JH; Siepen FAD; Hegenbart U; Schönland S; Kristen AV; Katus HA; Buss SJ
    J Cardiovasc Magn Reson; 2019 Aug; 21(1):53. PubMed ID: 31434577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of cardiac involvement and survival in patients with primary systemic light-chain amyloidosis: roles of the clinical, chemical, and 3-D speckle tracking echocardiography parameters.
    Lei C; Zhu X; Hsi DH; Wang J; Zuo L; Ta S; Yang Q; Xu L; Zhao X; Wang Y; Sun S; Liu L
    BMC Cardiovasc Disord; 2021 Jan; 21(1):43. PubMed ID: 33478398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis.
    Ridouani F; Damy T; Tacher V; Derbel H; Legou F; Sifaoui I; Audureau E; Bodez D; Rahmouni A; Deux JF
    J Cardiovasc Magn Reson; 2018 Aug; 20(1):58. PubMed ID: 30115079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and imaging characteristics of patients with cardiac amyloidosis- a single center observational study.
    Ingebrigtsen A; Saeed S; Larsen TH; Reikvam H
    Scand J Clin Lab Invest; 2024 May; 84(3):193-201. PubMed ID: 38709651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Native T1 and Extracellular Volume in Transthyretin Amyloidosis.
    Martinez-Naharro A; Kotecha T; Norrington K; Boldrini M; Rezk T; Quarta C; Treibel TA; Whelan CJ; Knight DS; Kellman P; Ruberg FL; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2019 May; 12(5):810-819. PubMed ID: 29550324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtype-Specific Interactions and Prognosis in Cardiac Amyloidosis.
    Sperry BW; Vranian MN; Hachamovitch R; Joshi H; Ikram A; Phelan D; Hanna M
    J Am Heart Assoc; 2016 Mar; 5(3):e002877. PubMed ID: 27013539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
    Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
    JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implication of relative regional strain ratio in cardiac amyloidosis.
    Senapati A; Sperry BW; Grodin JL; Kusunose K; Thavendiranathan P; Jaber W; Collier P; Hanna M; Popovic ZB; Phelan D
    Heart; 2016 May; 102(10):748-54. PubMed ID: 26830665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.